FOLH1 and nonpapillary renal cell carcinoma: Since the studies that reported the PSMA-targeted PET/CT detection rate in ccRCC used different modalities for its assessment and different benchmarks to calculate it [29,30,31,32,40], a meta-analysis could not be accomplished.